Journey Medical Corp Stock Performance
| DERM Stock | USD 3.58 0.28 7.25% |
The company retains a Market Volatility (i.e., Beta) of -0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Journey Medical are expected to decrease at a much lower rate. During the bear market, Journey Medical is likely to outperform the market. Journey Medical Corp has an expected return of -0.37%. Please make sure to check out Journey Medical treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Journey Medical Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Journey Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (7.25) | Five Day Return (19.91) | Year To Date Return (34.07) | Ten Year Return (62.32) | All Time Return (62.32) |
1 | Journey Medical Insiders Up US246k On US520.8k Investment | 02/22/2024 |
2 | Sale by Joseph Benesch of 2450 shares of Journey Medical | 02/23/2024 |
3 | New Journey Health Technology Group Co.,LTDs largest shareholders are retail investors with 35 percent ownership, private companies own 27 percent - Simply Wall... | 02/28/2024 |
4 | Journey Medical Corporation Not Doing Enough For Some Investors As Its Shares Slump 31 | 03/11/2024 |
5 | Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 | 03/15/2024 |
6 | Journey Medical Up as FDA Accepts Skin Disease Drug NDA | 03/19/2024 |
7 | DERM Stock Earnings Journey Medical Beats EPS, Beats Revenue for Q4 2023 | 03/22/2024 |
8 | Journey medical director Lindsay Rosenwald buys 68k in stock | 03/25/2024 |
9 | Journey Medical And 2 Other Stocks Under 4 Insiders Are Buying - TradingView | 03/28/2024 |
10 | 3 Biotech Stocks to Turn 5,000 Into 1 Million April 2024 | 04/11/2024 |
| Begin Period Cash Flow | 32 M |
Journey |
Journey Medical Relative Risk vs. Return Landscape
If you would invest 537.00 in Journey Medical Corp on January 20, 2024 and sell it today you would lose (179.00) from holding Journey Medical Corp or give up 33.33% of portfolio value over 90 days. Journey Medical Corp is currently does not generate positive expected returns and assumes 7.5993% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Journey, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Journey Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Journey Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Journey Medical Corp, and traders can use it to determine the average amount a Journey Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0486
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DERM |
Estimated Market Risk
| 7.6 actual daily | 67 67% of assets are less volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Journey Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Journey Medical by adding Journey Medical to a well-diversified portfolio.
Journey Medical Fundamentals Growth
Journey Stock prices reflect investors' perceptions of the future prospects and financial health of Journey Medical, and Journey Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Journey Stock performance.
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0074 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 67.23 M | ||||
| Shares Outstanding | 13.93 M | ||||
| Price To Earning | (9.50) X | ||||
| Price To Book | 4.33 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 79.18 M | ||||
| Gross Profit | 42.89 M | ||||
| EBITDA | 4.92 M | ||||
| Net Income | (3.85 M) | ||||
| Cash And Equivalents | 38.14 M | ||||
| Cash Per Share | 2.17 X | ||||
| Total Debt | 17.73 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.40 X | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | 5.24 M | ||||
| Earnings Per Share | (0.21) X | ||||
| Market Capitalization | 76.94 M | ||||
| Total Asset | 76.85 M | ||||
| Retained Earnings | (72.36 M) | ||||
| Working Capital | 14.59 M | ||||
| Current Asset | 217.23 M | ||||
| Current Liabilities | 25.9 M | ||||
About Journey Medical Performance
To evaluate Journey Medical Corp Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Journey Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Journey Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Journey Medical Corp market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Journey's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 139.73 | 132.74 | |
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.19) | (0.18) |
Things to note about Journey Medical Corp performance evaluation
Checking the ongoing alerts about Journey Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Journey Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Journey Medical Corp generated a negative expected return over the last 90 days | |
| Journey Medical Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 79.18 M. Net Loss for the year was (3.85 M) with profit before overhead, payroll, taxes, and interest of 42.89 M. | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from investorplace.com: 3 Biotech Stocks to Turn 5,000 Into 1 Million April 2024 |
- Analyzing Journey Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Journey Medical's stock is overvalued or undervalued compared to its peers.
- Examining Journey Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Journey Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Journey Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Journey Medical's stock. These opinions can provide insight into Journey Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Journey Stock analysis
When running Journey Medical's price analysis, check to measure Journey Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Journey Medical is operating at the current time. Most of Journey Medical's value examination focuses on studying past and present price action to predict the probability of Journey Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Journey Medical's price. Additionally, you may evaluate how the addition of Journey Medical to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Journey Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 4.343 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0074 | Return On Equity (0.21) |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.